Sigyn Therapeutics, Inc. (SIGY): Cost of Revenue
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2024-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$35.7K
Year ended 2019-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2019-12-31 | $35.7K | +267.2% | 2020-03-30, From 2019-01-01 |
| 2018-12-31 | $9.7K | -54.7% | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $21.4K | n/a | 2019-04-01, From 2017-01-01 |